(Q27014761)

English

Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

6 references

19 March 2019

23 March 2019

21 March 2019

30 May 2020

20 October 2022

25 October 2022

systematic review

1 reference

based on heuristic

inferred from title

Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention (English)

0 references

0 references

5 references

19 March 2019

23 March 2019

21 March 2019

30 May 2020

1 July 2020

RNA virus infectious disease

1 reference

1 July 2020

Hepatitis C virus

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Angelos Hatzakis

7

0 references

object named as

Vivian D. Hope

11

0 references

Jeffrey V. Lazarus

object named as

Jeffrey V. Lazarus

10

0 references

Peter Vickerman

object named as

Peter Vickerman

9

0 references

8

object named as

Maria Prins

1 reference

Helena Cortes Martins

0 references

Sharon J Hutchinson

0 references

1 reference

ORCID Public Data File 2021

author name string

Lucas Wiessing

1

1 reference

Marica Ferri

2

1 reference

Bart Grady

3

1 reference

Maria Kantzanou

4

1 reference

Ida Sperle

5

1 reference

Katelyn J. Cullen

6

1 reference

Catharina Matheï

12

1 reference

language of work or name

1 reference

publication date

2014

1 reference

28 July 2014

7 references

19 March 2019

23 March 2019

21 March 2019

30 May 2020

1 July 2020

20 October 2022

25 October 2022

8 references

19 March 2019

23 March 2019

21 March 2019

30 May 2020

1 July 2020

20 October 2022

25 October 2022

9

1 reference

7

1 reference

e103345

1 reference

copyright license

Creative Commons Attribution 4.0 International

7 references

Europe PubMed Central

19 March 2019

Europe PubMed Central

23 March 2019

Europe PubMed Central

21 March 2019

Europe PubMed Central

30 May 2020

Europe PubMed Central

1 July 2020

Europe PubMed Central

20 October 2022

Europe PubMed Central

25 October 2022

copyright status

0 references

on focus list of Wikimedia project

0 references

Barriers to hepatitis C treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

21 March 2017

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

21 March 2017

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

21 March 2017

CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

21 March 2017

Emergence of Hepatitis C Virus Genotype 4: Phylogenetic Analysis Reveals Three Distinct Epidemiological Profiles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

21 March 2017

Epidemiological dynamics of hepatitis C virus among 747 German individuals: new subtypes on the advance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

21 March 2017

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

21 March 2017

Global epidemiology of hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

21 March 2017

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

21 March 2017

Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

21 March 2017

The epidemiology of hepatitis C in a UK health regional population of 5.12 million

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

21 March 2017

Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

21 March 2017

Mortality among patients with cleared hepatitis C virus infection compared to the general population: a Danish nationwide cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

21 March 2017

Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

21 March 2017

Evolving epidemiology of hepatitis C virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

7 April 2017

Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Barriers and facilitators of hepatitis C screening among people who inject drugs: a multi-city, mixed-methods study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Using surveillance data to determine treatment rates and outcomes for patients with chronic hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

HEPATITIS C VIRUS GENOTYPES IN INJECTING DRUG USERS FROM ROMANIA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Mortality among people who inject drugs: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Treatment of chronic hepatitis C: current and future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Comparative effectiveness of antiviral treatment for hepatitis C virus infection in adults: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

The burden of liver disease in Europe: a review of available epidemiological data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Cost effectiveness of hepatitis C-related interventions targeting substance users and other high-risk groups: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Hepatitis C virus infection among drug addicts in Italy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Psychiatric morbidity among cocaine and heroin users in the community

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Hepatitis C prevalence in Denmark -an estimate based on multiple national registers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Low incidence of reinfection with the hepatitis C virus following treatment in active drug users in Amsterdam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Hepatitis C prevalence in injecting drug users in Europe, 1990-2007: impact of study recruitment setting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Decisions about lumping vs. splitting of the scope of systematic reviews of complex interventions are not well justified: a case study in systematic reviews of health care professional reminders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

HCV routes of transmission: what goes around comes around

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

What is killing people with hepatitis C virus infection?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Prevalence and correlates of HCV, HVB, and HIV infection among prison inmates and staff, Hungary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Psychiatric comorbidity and the persistence of drug use disorders in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Significant epidemiological changes in chronic hepatitis C infection: results of the nationwide HEPNET-GREECE cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Difficulties with interferon treatment in former intravenous drug users.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Should active injecting drug users receive treatment for chronic hepatitis C?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Molecular and epidemiological profiles of hepatitis C virus genotype 4 in Denmark

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Hepatitis C treatment for injection drug users: a review of the available evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Treatment of intravenous drug users with chronic hepatitis C: treatment response, compliance and side effects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Hepatitis C infection among injection drug users in Stockholm Sweden: prevalence and gender

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Changes in the prevalence of hepatitis C virus genotype among Italian injection drug users-relation to period of injection started

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Hepatitis C virus genotypes in 1,504 patients in Slovenia, 1993-2007.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Vulnerability to drug-related infections and co-infections among injecting drug users in Budapest, Hungary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Surveillance and epidemiology of hepatitis B and C in Europe - a review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

A comparison between the force of infection estimates for blood-borne viruses in injecting drug user populations across the European Union: a modelling study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

The effectiveness of behavioural interventions in the primary prevention of hepatitis C amongst injecting drug users: a randomised controlled trial and lessons learned

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Management of chronic hepatitis in drug addicts: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Limited uptake of hepatitis C treatment among injection drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

High incidence of hepatitis C virus reinfection within a cohort of injecting drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Impact of a harm-reduction policy on HIV and hepatitis C virus transmission among drug users: recent French data--the ANRS-Coquelicot Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Hepatitis C virus infection in Scotland: epidemiological review and public health challenges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Impact of hepatitis C infection on long-term mortality of injecting drug users from 1990 to 2002: differences before and after HAART.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Changes in risk behavior and dynamics of hepatitis C virus infections among young drug users in Amsterdam, the Netherlands

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

The hepatitis C virus epidemic among injecting drug users.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Failure to diagnose recent hepatitis C virus infections in London injecting drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Incidence of hepatitis C virus infection and associated risk factors among Scottish prison inmates: a cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Retrospective cohort study examining incidence of HIV and hepatitis C infection among injecting drug users in Dublin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Case-reporting of acute hepatitis B and C among injection drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Prevention and treatment of hepatitis C in injection drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

A method to detect the incidence of hepatitis C infection among injecting drug users in Glasgow 1993-98.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Managing chronic hepatitis C acquired through intravenous drug use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

HCV genotypes and age distribution in patients of Vienna and surrounding areas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Changes in the epidemiology of hepatitis C infection in Germany: shift in the predominance of hepatitis C subtypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 September 2017

Lower life expectancy among people with an HCV notification: a population-based linkage study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

31 May 2018

Towards hepatitis C eradication from the HIV-infected population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

31 May 2018

Hepatitis C among injecting drug users is two times higher in Stockholm, Sweden than in Rotterdam, the Netherlands

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

31 May 2018

Factors to improve the management of hepatitis C in drug users: an observational study in an addiction centre

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

31 May 2018

[Burden of disease and level of patient's medical care in substitution treatment for opiates].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

31 May 2018

Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

31 May 2018

Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

31 May 2018

HIV among injecting drug users in Europe: increasing trends in the East

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

31 May 2018

Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

31 May 2018

Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

31 May 2018

Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

31 May 2018

French consensus conference on hepatitis C: screening and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

31 May 2018

Management of chronic hepatitis C in French departments of internal medicine and infectious diseases

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Hepatitis C, stigma and cure

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Associations between availability and coverage of HIV-prevention measures and subsequent incidence of diagnosed HIV infection among injection drug users.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Bloodborne virus infections among drug users in Ireland: a retrospective cross-sectional survey of screening, prevalence, incidence and hepatitis B immunisation uptake

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

HCV seroconversion among never-injecting heroin users at baseline: no predictors identified other than starting injection.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Diagnosis of acute hepatitis C virus infection and estimated incidence in low- and high-risk English populations.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Prevalence and incidence of bloodborne viral infections among Danish prisoners.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Prevalence and distribution of hepatitis C subtypes in patients with opioid dependence

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Distribution of hepatitis C virus genotypes among injecting drug users in contact with treatment centers in Belgium, 2004-2005.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Decline in hepatitis B infection observed after 11 years of regional vaccination among Danish drug users

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Routine practice HCV infection screening with saliva samples: multicentric study in an intravenous drug user population

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Hepatitis C viral clearance in an intravenous drug-using cohort in the Dublin area.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Multiple viral infections in a group of intravenous drug users: hepatitis B virus exposure is the risk factor

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Identifying former injecting drug users infected with hepatitis C: an evaluation of a general practice-based case-finding intervention

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow's injecting drug user population.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Molecular analysis of hepatitis C virus infection in Bulgarian injecting drug users

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Genotypic and epidemiologic characteristics of hepatitis C virus infections among recent injection drug user and nonuser populations

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Genetic characterization of hepatitis C virus strains in Estonia: fluctuations in the predominating subtype with time

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Changes in epidemiological patterns of HCV infection and their impact on liver disease over the last 20 years in Greece

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Hepatitis C virus genotypes in a non-cirrhotic Italian population with chronic hepatitis C: correlation with clinical, virological and histological parameters. Results of a prospective multicentre study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Changing HCV genotypes distribution in Poland--relation to source and time of infection.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Influence of age and date of infection on distribution of hepatitis C virus genotypes and fibrosis stage

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Evaluation of the French national plan to promote screening and early management of viral hepatitis C, between 1997 and 2003: a comparative cross-sectional study in Poitou-Charentes region

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Risk Factors and predictors of human immunodeficiency virus infection among injection drug users

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Measures to reduce HIV infection have not been successful to reduce the prevalence of HCV in intravenous drug users.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Estimated liver fibrosis and its impact on all-cause mortality of HCV-monoinfected and HCV/HIV-coinfected drug users.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Male IDUs who have sex with men in England, Wales and Northern Ireland: are they at greater risk of bloodborne virus infection and harm than those who only have sex with women?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Community-based treatment for chronic hepatitis C in drug users: high rates of compliance with therapy despite ongoing drug use.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Hepatitis C infection among recent initiates to injecting in England 2000-2008: Is a national hepatitis C action plan making a difference?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Diagnosis of hepatitis C virus infection in Scotland's injecting drug user population

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

HEPACOM: multicenter, observational prospective study of outcome and monitoring of HCV positive antiviral-naïve patients managed in the French health care system

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Access to care of patients with chronic hepatitis C virus infection in a university hospital: Is opioid dependence a limiting condition?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Mortality in HIV-infected injection drug users with active vs cleared hepatitis C virus-infection: a population-based cohort study.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

All-cause and liver-related mortality in HIV positive subjects compared to the general population: differences by HCV co-infection.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

No impact of hepatitis C virus infection on mortality among drug users during the first decade after seroconversion

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

Prevention and treatment of hepatitis C in injection drug users

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103345

21 January 2018

The European Monitoring Centre for Drugs and Drug Addiction publishes the European Drug Report 2013: trends and developments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Gender differences in HIV risk behaviours among intravenous drug users in Catalonia, Spain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Referral of intravenous drug users for antiviral treatment: effectiveness of hepatitis C case-finding programmes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Decrease in health-related quality of life associated with awareness of hepatitis C virus infection among people who inject drugs in Scotland

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: a controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Risk factors for HBV/HIV/HCV in drug addicts: a survey of attendees of a department of pathological dependence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Prevalence of human immunodeficiency virus and hepatitis C virus, and associated factors among injecting drug users in Catalonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Assessment and proposal of a new combination of screening criteria for hepatitis C in France

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

[Current situation and trends in the hepatitis C virus genotype distribution among injecting drug users in the Czech Republic]

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Changes in hepatitis C virus infection routes and genotype distribution in a Lithuanian cohort with chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Retention rate and side effects in a prospective trial on hepatitis C treatment with pegylated interferon alpha-2a and ribavirin in opioid-dependent patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Prevalence and incidence of hepatitis C in injecting drug users attending genitourinary medicine clinics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Clinical trial: a primary-care-based model for the delivery of anti-viral treatment to injecting drug users infected with hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

A survey of HIV and HCV among female prison inmates in Portugal.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

European monitoring of notifications of hepatitis C virus infection in the general population and among injecting drug users (IDUs) - the need to improve quality and comparability.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Market uptake of new antiviral drugs for the treatment of hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

[Reporting chronic hepatitis B and C in Denmark].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Effectiveness of a multi-disciplinary standardized management model in the treatment of chronic hepatitis C in drug addicts engaged in detoxification programmes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Experience of hepatitis C among current or former heroin users attending general practice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Follow-up studies of treatment for hepatitis C virus infection among injection drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Predictive markers of HIV and HCV infection and co-infection among inmates in a Spanish prison

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Management of hepatitis C in active drugs users: experience of an addiction care hepatology unit.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

[Rate of infection by blood-borne viruses in active heroin users in 3 Spanish cities].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Profile of drug users admitted to a hospital

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Risk factors, clinical features and genotype distribution of diagnosed hepatitis C virus infections: a pilot for a sentinel laboratory-based surveillance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Hepatitis C virus screening in drug users in an addiction out-patient unit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Treatment of hepatitis C infection in injection drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113410

28 November 2018

Former addicts face barriers to treatment for HCV

1 reference

https://pubmed.ncbi.nlm.nih.gov/25068274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Prevalence of hepatitis C virus genotypes in the area of El Ferrol (La Coruña, Spain)]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25068274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Hepatitis C virus infection in a first level rural hospital: descriptive study in the decade 1991-1999]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25068274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and risk factors of HIV, hepatitis B and hepatitis C in a forensic population of rapists and child molesters

1 reference

https://pubmed.ncbi.nlm.nih.gov/25068274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25068274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Incidence and risk factors of HCV infection in a cohort of intravenous drug users in the North and East of France]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25068274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Infectious diseases in problem drug users hospitalized in the infectious ward of the Motol University Hospital in 2002-2005]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25068274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C action plan for Scotland: phase II (May 2008-March 2011)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25068274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continued high prevalence of HIV, HBV and HCV among injecting and noninjecting drug users in Italy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25068274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland

1 reference

https://pubmed.ncbi.nlm.nih.gov/25068274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0103345

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2014PLoSO...9j3345W

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27014761&oldid=2104975356"